Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 5 Issue 4

In Silico Study of Myricetin and Quercetin as Immunomodulator Candidates for Prevent SARS-CoV-2

Anna Yuliana*, Saeful Amin, Ira Rahmiyani and Meita Dea Ristiani

Faculty of Pharmacy, Bakti Tunas Husada University

*Corresponding Author: Anna Yuliana, Faculty of Pharmacy, Bakti Tunas Husada University.

Received: February 24, 2022; Published: March 23, 2022


Background: SARS-CoV-2 virus infection at this time has attacked various countries and becomes a threat that needs to be watched out for, the search for preventive treatment continues to be carried out to significantly prevent it. Antibodies against spikes that neutralize viral infections have potential as a therapy. Purpose of this study was to identify myricetin and quercetin, which were thought to have acted as immunomodulators for prevent SARS-CoV-2 using in silico study.

Material and Methods: Samples of 3D structure compounds from PubChem with the 3D structure of Fab-Antibody protein were docked using AutoDockTools and SwissDock and then validated by performing Molecular Dynamic. The final conformational results were then visualized using the Biovia Discovery studio, analyzed the effectiveness of the docking program, pharmacokinetics, toxicity, and dynamic programming using the Ramachandran plot.

Result: Significant results were obtained where quercetin had good activity at the 7JMO receptor with AutoDockTools and SwissDock where the binding affinity was -7.36 and -8.14. as well as the test compound myricetin, had a significant result having the best activity at the 7KZA receptor with a binding affinity value of -7.36 on AutoDockTools and -8.22 on SwissDock. And validated with the results of Molecular Dynamic having stable binding to the 7KZA receptor on the two test compounds.

Conclusion: From the data presented, it can be concluded that myricetin and quercetin have the potential activity as immunomodulators candidate for prevent SARS-CoV-2.

Keywords: Quercetin; Myricetin; SARS-CoV-2; Immunomodulator; In Silico


  1. Susilo Adityo., et al. "Coronavirus disease 2019: Tinjauan literatur terkini”. Jurnal Penyakit Dalam Indonesia1 (2020): 45-67.
  2. Sanders James M., et al. "Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review”. JAMA18 (2020): 1824-1836.
  3. Hanifah Lil and Kiptiyah Kiptiyah. "Potensi kesambi (Scheichera oleosa) sebagai kandidat imunomodulator”. Prosiding Seminar Nasional Biologi1 (2020).
  4. Muttaqin Fauzan Zein. "Molecular Docking and Molecular Dynamic Studies of Stilbene Derivative Compounds As Sirtuin-3 (Sirt3) Histone Deacetylase Inhibitor on Melanoma Skin Cancer and Their Toxicities Prediction”. Journal of Pharmacopolium2 (2019).
  5. Alonso Hernan., et al. "Combining docking and molecular dynamic simulations in drug design”. Medicinal Research Reviews5 (2006): 531-568.
  6. Rastini M B O., et al. "Molecular Docking Aktivitas Antikanker Dari Kuersetin Terhadap Kanker Payudara Secara In Silico”. Jurnal Kimia (2019): 180.
  7. Saputra Diajeng Putri Dwinda and N M P Susanti. "Molecular Docking Sianidin dan Peonidin sebagai Antiinflamasi pada Aterosklerosis Secara In Silico”. Jurnal Farmasi Udayana1 (2018): 28-33.
  8. Ruswanto Ruswanto. "Molecular docking empat turunan isonicotinohydrazide pada mycobacterium tuberculosis enoyl-acyl carrier protein reductase (InhA)”. Jurnal Kesehatan Bakti Tunas Husada: Jurnal Ilmu-ilmu Keperawatan, Analis Kesehatan dan Farmasi1 (2015).
  9. Sharma Ravi Datta., et al. "High temperature unfolding of Bacillus anthracis amidase-03 by molecular dynamics simulations”. Bioinformation10 (2009): 430.
  10. Prasetiawati Riska., et al. "Molecular docking study of anthocyanidin compounds against Epidermal Growth Factor Receptor (EGFR) as anti-lung cancer”. Indonesian Journal of Pharmaceutical Science and Technology1 (2021): 8-20.
  11. Prasetiawati Riska., et al. "Molecular Docking Dtudy of Xanthone Derivattive Compounds of Mangosteen Rind (Garcinia mangostana L.) to ER-α (Estrogen Receptor Alfa) and AND ER-β (Estrogen Receptor Beta) as An ti Breastcancer" (2018).
  12. Chemical Computing Group Inc. "Molecular operating environment (MOE)”. (2016). 1-17
  13. Yuliana Anna., et al. "In Silico Study on Testing Antidiabetic Compounds Candidate from Azaphilone Mold Monascus sp”. Microbiology Indonesia2 (2020): 2-2.
  14. Pangastuti Ardini., et al. "Mengungkap potensi senyawa alami dari cabai (Capsicum annuum L.) sebagai agen anti-autism melalui teknik reverse docking”. Prosiding Semnas Hayati IV. Universitas Nusantara PGRI Kediri (2016): 123-129.
  15. Suhirman Sintha and Christina Winarti. "Prospek dan fungsi tanaman obat sebagai imunomodulator”. Balai Penelitian Tanaman Obat dan Aromatik. hal (2010): 121-131.
  16. Nurbaiti Santi. "Stabilitas termal dan pergerakan dinamis klenow-like DNA polimerase I ITB-1 berdasarkan simulasi dinamika molekul”. Disertasi Program Studi Kimia Institut Teknologi Bandung (2009).
  17. Sukmayadi Asep Edi., et al. "Aktivitas imunomodulator ekstrak etanol daun tempuyung (Sonchus arvensis)”. Indonesian Journal of Pharmaceutical Science and Technology1.2 (2014): 42.
  18. Daslina Daslina., et al. "Pengaruh pemberian glutamin pada kemampuan fagositosis makrofag terhadap Pseudomonas Aeruginosa”. Jurnal Kesehatan Andalas3 (2015).
  19. Arwansyah Arwansyah., et al. "Simulasi docking senyawa kurkumin dan analognya sebagai inhibitor reseptor androgen pada kanker prostat”. Current Biochemistry1 (2014): 11-19.
  20. Syahputra Gita. "Simulasi docking kurkumin enol, bisdemetoksikurkumin dan analognya sebagai inhibitor enzim12-lipoksigenase”. Jurnal Biofisika1 (2014): 55-67.


Citation: Anna Yuliana., et al. “In Silico Study of Myricetin and Quercetin as Immunomodulator Candidates for Prevent SARS-CoV-2". Acta Scientific Microbiology 5.4 (2022): 125-133.


Copyright: © 2022 Anna Yuliana., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US